Cranberry juice

Phase 2Small molecule

NNational Center for Complementary and Integrative Health (NCCIH)

Cranberry juice is one of 48 small molecule programs targeting Recurrent urinary tract infections. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Recurrent Urinary Tract InfectionsActive, not recruiting

Urinary Tract InfectionActive, not recruiting

Recurrent Urinary Tract InfectionsPhase 2

Active, not recruiting

Urinary Tract InfectionPreclinical

Active, not recruiting

Competition

Competitive Landscape

163 competitors in Urinary Tract Infection

#DrugCompanyPhaseTrials

Medrol

Pfizer

Phase 3

1 2

Merrem

BB. Braun Medical Inc.

Phase 3

7 3

Decadron

AAspen Global Incorporated

Phase 3

1 4

Piperacillin/tazobactam

Pfizer

Phase 3

1 5

Prulifloxacin

Merck & Co.

Phase 3

1 6

Amoxicillin/clavulanate Potassium

Johnson & Johnson

Phase 3

1 7

Amoxicillin/clavulanate

Bayer

Phase 3

1 8

Imipenem+cilastatin/relebactam

Merck & Co.

Phase 3

1 9

Xerava

TTetraphase Pharmaceuticals, Inc

Phase 3

2 10

Expec9v

Johnson & Johnson

Phase 3

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Urinary Tract Infection4 trials

Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract Infections

Completed·NNational Center for Complementary and Integrative Health (NCCIH)·N/A·NCT00084201·18 enrolled

Identification of the Cranberry Juice Compounds That Prevent Urinary Tract Infections

Completed·NNational Center for Complementary and Integrative Health (NCCIH)·N/A·NCT00087828·5 enrolled

Cranberry Juice in the Prevention of Urinary Tract Infections in Children

Completed·UUniversity of Oulu·N/A·NCT00638170·262 enrolled

Show 1 more trial

Cranberry Juice for Treatment of Urinary Tract Infections

Completed·NNational Center for Complementary and Integrative Health (NCCIH)·Phase 2/3·NCT00093054·319 enrolled

Recurrent urinary tract infections2 trials

Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)

Unknown status·NNational Center for Complementary and Integrative Health (NCCIH)·Phase 2·NCT00100061·350 enrolled

Cranberry Juice for the Prevention of Recurrent Urinary Tract Infections

Completed·NNational Center for Complementary and Integrative Health (NCCIH)·Phase 2·NCT00128128·176 enrolled

Pregnancy1 trial

Cranberry Juice for Preventing Bacteria in Urine During Pregnancy

Completed·NNational Center for Complementary and Integrative Health (NCCIH)·Phase 1·NCT00093938·360 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Cranberry juice. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Cranberry juice compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Cranberry juice. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Center for Complementary and Integrative Health (NCCIH) company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: NNational Center for Complementary and Integrative Health (NCCIH)

Cranberry juice

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Urinary Tract Infection4 trials

Recurrent urinary tract infections2 trials

Pregnancy1 trial

References

Drug Info

Quick Facts

Related News